M
Manuela Pilleri
Researcher at University of Barcelona
Publications - 39
Citations - 1648
Manuela Pilleri is an academic researcher from University of Barcelona. The author has contributed to research in topics: Parkinson's disease & Deep brain stimulation. The author has an hindex of 20, co-authored 37 publications receiving 1452 citations. Previous affiliations of Manuela Pilleri include Yahoo!.
Papers
More filters
Journal ArticleDOI
Effects of Bilateral Subthalamic Stimulation on Cognitive Function in Parkinson Disease
Montse Alegret,Carme Junqué,Francesc Valldeoriola,Pere Vendrell,Manuela Pilleri,Jordi Rumià,Eduardo Tolosa +6 more
TL;DR: Therapy with STN-DBS improves motor symptoms in PD without any clinically relevant neuropsychological deterioration.
Journal ArticleDOI
Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease.
Pablo Martinez-Martin,Francesc Valldeoriola,Eduardo Tolosa,Manuela Pilleri,José Luis Molinuevo,Jordi Rumià,Enric Ferrer +6 more
TL;DR: STN‐DBS significantly improves important aspects of QoL in patients with advanced Parkinson's disease, as measured by the PDQ‐39, which shows significant benefit in the motor manifestations and complications of disease.
Journal ArticleDOI
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy
Annamaria Vallelunga,Marco Ragusa,Stefania Di Mauro,Tommaso Iannitti,Manuela Pilleri,Roberta Biundo,Luca Weis,Cinzia Di Pietro,Angela De Iuliis,Alessandra Nicoletti,Mario Zappia,Michele Purrello,Angelo Antonini +12 more
TL;DR: The results suggest that cmiRNA signatures discriminate PD from MSA patients and healthy controls and may be considered specific, non-invasive biomarkers for differential diagnosis.
Journal ArticleDOI
Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: long-term follow-up of patients.
Francesc Valldeoriola,Manuela Pilleri,Eduardo Tolosa,José Luis Molinuevo,Jordi Rumià,Enric Ferrer +5 more
TL;DR: STN‐DBS is useful in the treatment of advanced PD and in some patients it is possible to maintain this therapy alone in the long term with the additional benefit of avoiding motor fluctuations and dyskinesias.
Journal ArticleDOI
Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale
Angelo Antonini,Giovanni Abbruzzese,Luigi Ferini-Strambi,Barbara C. Tilley,Jing Huang,Glenn T. Stebbins,Christopher G. Goetz,Paolo Barone,Monica Bandettini di Poggio,Giovanni Fabbrini,Flavio Di Stasio,Michele Tinazzi,Tommaso Bovi,Silvia Ramat,Sara Meoni,Gianni Pezzoli,Margherita Canesi,Paolo Martinelli,Cesa Scaglione,Aroldo Rossi,Nicola Tambasco,Gabriella Santangelo,Marina Picillo,Letterio Morgante,Francesca Morgante,Rocco Quatrale,Mariachiara Sensi,Manuela Pilleri,Roberta Biundo,Giampietro Nordera,Antonella Caria,Claudio Pacchetti,Roberta Zangaglia,Leonardo Lopiano,Maurizio Zibetti,Mario Zappia,Alessandra Nicoletti,Aldo Quattrone,Maria Salsone,Gianni Cossu,Daniela Murgia,Alberto Albanese,Francesca Del Sorbo +42 more
TL;DR: The Italian version of the MDS-UPDRS reaches the criterion to be designated as an Official Translation and is now available for use and this protocol will serve as outline for further validation of this in multiple languages.